Fierce Healthcare
AUGUST 10, 2023
Medicare Part D drug prices have increased by an average of 226% since market entry. These 25 drugs are responsible for $80.9 billion in total Part D spending in 2021. | A report from AARP broke down how popular brand-name drugs have continued to rise in price and exceed inflation.
Drug Topics
AUGUST 11, 2023
HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 7, 2023
Researchers say vitamin D supplementation could be a low-cost and effective avenue for the reduction of insulin resistance and better outcomes in preventing and treating diabetes.
STAT
AUGUST 11, 2023
Nearly every hospital pharmacy across the U.S. is experiencing shortages of prescription drugs. And the problem has become so bad – especially for chemotherapies — that one-third of hospital pharmacists reported their institutions are rationing, delaying, or canceling treatments or procedures, according to a new survey. Specifically, 99% of hospitals pharmacists reported shortages, which is causing 85% to ration treatments and 84% to rely on different dosages.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
AUGUST 11, 2023
It’s been a rough summer for pharmaceutical companies trying to resolve lawsuits by declaring bankruptcy. | The Supreme Court has halted Purdue Pharma’s $6-billion bankruptcy settlement, which granted the company’s former owners—the Sackler family—immunity from civil suits related to the opioid crisis.
Drug Topics
AUGUST 10, 2023
A study published in the Lancet found that patients who had previously tested positive for COVID-19 had lower cognitive accuracy compared to negative controls.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
AUGUST 11, 2023
The last time Kim Kardashian posted about medical imaging, it was to prove her butt was real. Now, she’s praising its ability to find aneurysms and cancers before they turn deadly. Kardashian’s Instagram post this week about Prenuvo, which sells full-body MRI scans that can run in the thousands of dollars, has renewed a long-running debate about whether the tests are actually valuable or just run the risk of clogging hospitals with false positives and unnecessary follow-ups from we
Fierce Healthcare
AUGUST 11, 2023
Microsoft rolled out a new electronic health records cloud database solution, leveraging Azure Large Instances, that enables health systems to scale capacity for high-volume workloads. | Microsoft rolled out a new electronic health records cloud database solution, leveraging Azure Large Instances, that enables health systems to scale capacity for high-volume workloads.
Drug Topics
AUGUST 8, 2023
Approximately 1 in 8 women in the United States experience postpartum depression.
Pharmacy Times
AUGUST 11, 2023
Jennifer Chesak, author of The Psilocybin Handbook for Women, discusses how estrogen can affect binding at the serotonin receptor sites, causing psilocybin to impact women’s bodies differently.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
AUGUST 11, 2023
One person has died and at least four have been sickened by tuberculosis in infected bone materials, an outbreak that has cast a spotlight on the shortcomings of testing for such tissue products. It’s the second tuberculosis outbreak linked to the biomaterial device company, Aziyo Biologics. In 2021, Aziyo’s product killed eight people after orthopedic and dental surgeons unwittingly implanted infected bone grafts into patients.
PharmExec
AUGUST 11, 2023
How pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.
Drug Topics
AUGUST 10, 2023
After sessions end, head out to explore the city of San Diego.
Pharmacy Times
AUGUST 11, 2023
Gretchen Garofoli, PharmD, an associate professor at the West Virginia School of Pharmacy, discusses the current recommendations for COVID-19, respiratory syncytial virus (RSV), and influenza vaccines and vaccine hesitancy.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 11, 2023
HELSINKI — It was the quiet that stood out to Tarja Sironen at the fur farm. A specialist in emerging infectious diseases, Sironen has conducted research at fur farms for years. She helped develop a Covid vaccine that was deployed to the country’s mink population during the pandemic. She knows the industry well.
Fierce Pharma
AUGUST 11, 2023
Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis (ALS) drug Relyvrio continues to wow Wall Street. | Amylyx’s amyotrophic lateral sclerosis drug Relyvrio ​​​​​​​continues to wow Wall Street. The drug brought in $98.2 million revenue in the second quarter, handily beating analysts’ consensus estimates of below $92 million.
The Checkup by Singlecare
AUGUST 11, 2023
Pain management is essential to the treatment plan when someone is suffering. However, figuring out the right course of action for a particular condition can be difficult. There are many ways to worsen and prolong pain if not managed properly. People with diverticulitis often experience abdominal pain during or after eating a meal. Eating is a part of everyday life, so coping with a condition that is worsened by eating can be challenging.
Pharmacy Times
AUGUST 11, 2023
Unexpectedly, the highest increases in delirium compared to projections were in the 66 to 74 years of age group, which could have important personal and societal repercussions, such as earlier development of dementia.
STAT
AUGUST 11, 2023
So many promising medical innovations never reach their full potential as therapies or cures, languishing instead in a metaphoric place many of us in biotech know as “the Valley of Death.” This valley represents the gap between when a scientist makes a discovery and when that work has reached the point when a pharmaceutical company will license it, or a venture capital firm will invest in it, to get it to the point to help the patients who need it.
Fierce Pharma
AUGUST 11, 2023
Less than a month after the family of Henrietta Lacks reached a settlement with Thermo Fisher over its use of Lacks’ cells, another drugmaker stands accused of profiting from a racist medical syste | Less than a month after the family of Henrietta Lacks reached a settlement with Thermo Fisher over its use of Lacks’ cells, another drugmaker stands accused of profiting from a racist medical system.
Fierce Healthcare
AUGUST 11, 2023
Access to care for Medicaid fee-for-service beneficiaries with substance use disorder has improved from 2014 until 2021, but much more can be done to improve it further, researchers say. | There have been substantial improvements in coverage for substance use disorder and opioid use disorder since 2014, according to a study in JAMA Network. Nonetheless, there’s room for yet more improvement.
Pharmacy Times
AUGUST 11, 2023
New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.
PharmExec
AUGUST 11, 2023
From public defender to spearheading the adoption of innovative drugs, Wendy Short Bartie, senior VP and general manager for the hematology and cell therapy division at Bristol Myers Squibb, has remained a steadfast patient advocate—working to fulfill unmet medical needs and bring treatments to as many people as possible.
The Checkup by Singlecare
AUGUST 11, 2023
Propranolol is an old drug that just won’t go away, for good reason. It touts a 50-year history of utility, originally as a treatment for heart disease and later as a preventive treatment for migraine, a use that has landed it on the World Health Organization’s list of essential medications. A role for propranolol that you may find more interesting is in the treatment of anxiety.
Fierce Pharma
AUGUST 11, 2023
Bristol Myers Squibb has laid off more than 100 employees amid a reconfiguration of expenses that follows disappointing earnings results. | Bristol Myers Squibb has laid off more than 100 employees amid a reconfiguration of expenses that follows disappointing earnings results.
Pharmacy Times
AUGUST 10, 2023
Results of phase 3 trials could lead to the approval of remibrutinib to provide more effective and controlled treatment of chronic spontaneous urticaria than H1-antihistamines.
STAT
AUGUST 11, 2023
WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies. The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages.
Board Vitals - Pharmacist
AUGUST 10, 2023
The journey to becoming a certified surgical technologist is a noble one, filled with dedication, perseverance, and a commitment to excellence. At the heart of this journey lies a crucial milestone – the NBSTSA Surgical Technology Exam. This comprehensive exam contains 175 questions (150 graded) with a pass rate of just 73.7% in 2020. How can you best prepare for the CST exam ?
Fierce Pharma
AUGUST 10, 2023
In this episode of "The Top Line," Teresa Carey talks with Dr. | This week on "The Top Line," we discuss left-handedness and its significance in neurodevelopmental and psychiatric disorder research.
Pharmacy Times
AUGUST 9, 2023
Lack of information and access to health care, stigma, discrimination, criminalization, and privacy concerns are among the barriers some groups face when trying to obtain preventative HIV medications.
STAT
AUGUST 10, 2023
Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.
Fierce Healthcare
AUGUST 10, 2023
Mantra Health, a digital mental health provider for higher education, is joining forces with adolescent-focused Charlie Health to broaden access for students seeking higher levels of care. | The partners will connect college and university students who require a higher level of mental health care to Charlie Health’s virtual intensive outpatient program.
Fierce Pharma
AUGUST 10, 2023
After Pfizer allegedly fired a compliance manager for raising the flag on potential fraud activity in China, the former employee is hitting back. | Frank Han, Pfizer's former director of global compliance analytics, has filed a civil complaint against the drugmaker. Han claims he was terminated for identifying potential issues relating to the Foreign Corrupt Practices Act.
Pharmacy Times
AUGUST 11, 2023
Despite the low uptake of healthy lifestyle behaviors to achieve 5% weight loss or greater, the probability of weight loss increased among individuals with higher initial BMI.
Expert insights. Personalized for you.
98 
Let's personalize your content